Dow Hits Teva, Actavis With Suit Over Generic Acne Med
Dow Pharmaceutical Sciences Inc. and Valeant Pharmaceuticals slapped Actavis Laboratories UT Inc. with a patent infringement suit in New Jersey federal court Wednesday over Actavis' abbreviated new drug application to market...To view the full article, register now.
Already a subscriber? Click here to view full article